A male COVID-19 patient who was taken into Prague's Faculty Hospital folowing lung failure is recovering and has been taken off extracorporeal life support. News appeared that this was a result of him being granted experimental treatment incvolving the drug known as redemsivir. However, the head of the Anastesiology, Resuscitation and Intensive Care Unit, Jan Bláha, said on Friday that there was no reason for optimism yet. Furthemore, doctors from the hospital have said that the patient's ilness began improving before he took the drug.
The patient received the medication as part of experimental treatment. However, many others who asked for redemsivir treatment have been declined due to the limited numbers of the drug.
Deputy Health Minister Roman Prymula said that the state is negotiating further use of the drug with supliers.
Milan Kundera is a ‘moral relativist’ with much to hide, says Czech author of controversial new biography
Czech Republic opens up to more tourists from Europe and beyond as coronavirus travel restrictions eased
Janek Rubeš: The only question I get – and there are thousands of them – is, Can we come to Prague?
Facemask requirement eased but new restrictions for area hit by spike in Covid-19 cases
Czech nation pays tribute to Milada Horáková on 70th anniversary of her judicial murder